Allucent (India) Private Limited logo

Allucent (India) Private Limited

Coordinates clinical trials for pharmaceutical products in India since 2002.
2002 | Bangaluru, Karnataka (India) | Active

Last Updated:

October 24, 2024
HomeCompanyAllucent (India) Private Limited

Who are the key members and board of directors at Allucent (India)?

Board Members(2)

NameDesignationAppointment DateStatus
Sivakumar Subramanian In Director 21-Feb-2023Current
Christopher Brennan Us Director 27-Sep-2022Current

Financial Performance of Allucent (India).

Allucent (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.23% increase. The company also saw a substantial improvement in profitability, with a 78.8% increase in profit. The company's net worth Soared by an impressive increase of 32.61%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
74.23%
Revenue from Operations
74.27%
Total Assets
39.05%
Profit or Loss
78.80%
Net Worth
32.61%
EBITDA
89.40%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Allucent (India)?

Allucent (India) has a workforce of 177 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Allucent (India)

Recent activity within the organization

  • Annual General Meeting

    Allucent (India) Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

    29 Sep 2023

  • Balance Sheet

    Allucent (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

    31 Mar 2023

  • Director Appointment

    Sivakumar Subramanian was appointed as a Director was appointed as a Director on 21 Feb 2023 & has been associated with this company since 1 year 10 months .

    21 Feb 2023

  • Director Appointment

    Christopher Scott Brennan was appointed as a Director was appointed as a Director on 27 Sep 2022 & has been associated with this company since 2 years 2 months .

    27 Sep 2022

  • Company Incorporation

    Allucent (India) Private Limited was registered on 27 Nov 2002 with Roc Bangalore & aged 22 years 25 days as per MCA records.

    27 Nov 2002

Frequently asked questions

  • Allucent (India) Private Limited was incorporated on 27 Nov 2002.

  • The authorized share capital of Allucent (India) Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Allucent (India) Private Limited.

    • Sivakumar Subramanian
    • Christopher Scott Brennan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Allucent (India) Private Limited is Unit No. 602 6Th Floor Rmz Ecoworld Campus 31 Sarjapur Marathahalli Orr Devarabeesanahalli Village, Varthur Hobli India, Bangalore South, Karnataka, 560103.

  • The corporate identification number (CIN) of Allucent (India) Private Limited is U51397KA2002PTC031282 and the company number is 031282 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Allucent (India) Private Limited is https://www.allucent.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Allucent (India) Private Limited has risen by 74.23%.

  • As Per 2023 financial reports, 177 employees are currently employed by Allucent (India) Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Allucent (India) Private Limited has experienced an upsurge of 32.61%.

  • The most recent Balance Sheet for Allucent (India) Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Pharma Contract R&D